# A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants

> **NCT04392271** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 4 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3372689
- **DIAGNOSTIC_TEST:** [18F]LSN3316612

## Key facts

- **NCT ID:** NCT04392271
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-06
- **Primary completion:** 2020-10-14
- **Final completion:** 2020-10-14
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04392271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04392271, "A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04392271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*